Literature DB >> 17722100

Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state.

Chandan Bhugra1, Michael J Pikal.   

Abstract

Though there is an advantage in using the higher solubility amorphous state in cases where low solubility limits absorption, physical instability poses a significant barrier limiting its use in solid oral dosage forms. Unlike chemical instability, where useful accelerated stability testing protocols are common, no methodology has been established to predict physical instability. Therefore, an understanding of the factors affecting crystallization from the amorphous state is not only important from a scientific perspective but also has practical applications. Crystallization from the amorphous matrix has been linked to the molecular mobility in the amorphous matrix and recent research has focused on developing the link between these two fundamental properties of glass forming materials. Although researchers have been actively working in this area for some time, there is no current review describing the present state of understanding of crystallization from the amorphous state. The purpose of this review therefore is to examine the roles of different factors such as molecular mobility, thermodynamic factors, and the implication of different processing condition, in crystallization from the amorphous state. We believe an increased understanding of the relative contributions of molecular mobility and processing conditions are vital to increased usage of the amorphous state in solid oral dosage forms. 2007 Wiley-Liss, Inc

Mesh:

Year:  2008        PMID: 17722100     DOI: 10.1002/jps.21138

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  36 in total

1.  Origin of two modes of non-isothermal crystallization of glasses produced by milling.

Authors:  Sayantan Chattoraj; Chandan Bhugra; Chitra Telang; Li Zhong; Zeren Wang; Changquan Calvin Sun
Journal:  Pharm Res       Date:  2011-12-16       Impact factor: 4.200

2.  A practical method to predict physical stability of amorphous solid dispersions.

Authors:  Stéphanie Greco; Jean-René Authelin; Caroline Leveder; Audrey Segalini
Journal:  Pharm Res       Date:  2012-03-16       Impact factor: 4.200

Review 3.  Stability of amorphous pharmaceutical solids: crystal growth mechanisms and effect of polymer additives.

Authors:  Ye Sun; Lei Zhu; Tian Wu; Ting Cai; Erica M Gunn; Lian Yu
Journal:  AAPS J       Date:  2012-03-21       Impact factor: 4.009

4.  Using thermally stimulated current (TSC) to investigate disorder in micronized drug substance produced at different milling energies.

Authors:  Rachel Forcino; Jeffrey Brum; Marc Galop; Yan Sun
Journal:  Pharm Res       Date:  2010-08-10       Impact factor: 4.200

Review 5.  High-throughput biophysical analysis of protein therapeutics to examine interrelationships between aggregate formation and conformational stability.

Authors:  Rajoshi Chaudhuri; Yuan Cheng; C Russell Middaugh; David B Volkin
Journal:  AAPS J       Date:  2013-10-31       Impact factor: 4.009

6.  Influence of preparation methods on solid state supersaturation of amorphous solid dispersions: a case study with itraconazole and eudragit e100.

Authors:  Sandrien Janssens; Ann De Zeure; Amrit Paudel; Jan Van Humbeeck; Patrick Rombaut; Guy Van den Mooter
Journal:  Pharm Res       Date:  2010-03-02       Impact factor: 4.200

7.  Supersolubilization and amorphization of a model basic drug, haloperidol, by interaction with weak acids.

Authors:  Saumya Singh; Tapan Parikh; Harpreet K Sandhu; Navnit H Shah; A Waseem Malick; Dharmendra Singhal; Abu T M Serajuddin
Journal:  Pharm Res       Date:  2013-02-21       Impact factor: 4.200

8.  An investigation of nifedipine miscibility in solid dispersions using Raman spectroscopy.

Authors:  Sujinda Keratichewanun; Yasuo Yoshihashi; Narueporn Sutanthavibul; Katsuhide Terada; Jittima Chatchawalsaisin
Journal:  Pharm Res       Date:  2015-02-12       Impact factor: 4.200

9.  Amorphous solid dispersions of sulfonamide/Soluplus® and sulfonamide/PVP prepared by ball milling.

Authors:  Vincent Caron; Yun Hu; Lidia Tajber; Andrea Erxleben; Owen I Corrigan; Patrick McArdle; Anne Marie Healy
Journal:  AAPS PharmSciTech       Date:  2013-02-07       Impact factor: 3.246

10.  Evaluation of drug-polymer miscibility in amorphous solid dispersion systems.

Authors:  Alfred C F Rumondor; Igor Ivanisevic; Simon Bates; David E Alonzo; Lynne S Taylor
Journal:  Pharm Res       Date:  2009-09-22       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.